BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18508547)

  • 1. Role of Toll like receptor-activated dendritic cells in the development of autoimmunity.
    Granucci F; Zanoni I
    Front Biosci; 2008 May; 13():4817-26. PubMed ID: 18508547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of innate immune responses in autoimmune disease development.
    Waldner H
    Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central role of dendritic cells in the regulation and deregulation of immune responses.
    Granucci F; Zanoni I; Ricciardi-Castagnoli P
    Cell Mol Life Sci; 2008 Jun; 65(11):1683-97. PubMed ID: 18327662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.
    Baccala R; Hoebe K; Kono DH; Beutler B; Theofilopoulos AN
    Nat Med; 2007 May; 13(5):543-51. PubMed ID: 17479100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferons (alpha/beta) in immunity and autoimmunity.
    Theofilopoulos AN; Baccala R; Beutler B; Kono DH
    Annu Rev Immunol; 2005; 23():307-36. PubMed ID: 15771573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of TLR-dependent and independent pathways in autoimmunity].
    Kumagai Y; Akira S
    Nihon Rinsho; 2009 Mar; 67(3):487-93. PubMed ID: 19280921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity.
    Ah Kioon MD; Laurent P; Chaudhary V; Du Y; Crow MK; Barrat FJ
    Immunol Rev; 2024 May; 323(1):241-256. PubMed ID: 38553621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of TLR inhibitors for the treatment of autoimmune diseases.
    Barrat FJ; Coffman RL
    Immunol Rev; 2008 Jun; 223():271-83. PubMed ID: 18613842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
    Krieg AM; Vollmer J
    Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationship of dendritic cells, type 1 interferon system, regulatory T cells and toll-like receptors and their role in lichen planus and lupus erythematosus -- a literature review.
    Trucci VM; Salum FG; Figueiredo MA; Cherubini K
    Arch Oral Biol; 2013 Oct; 58(10):1532-40. PubMed ID: 23845753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity.
    Psarras A; Alase A; Antanaviciute A; Carr IM; Md Yusof MY; Wittmann M; Emery P; Tsokos GC; Vital EM
    Nat Commun; 2020 Dec; 11(1):6149. PubMed ID: 33262343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal Modulation of Dendritic Cells Differentiation, Maturation and Function: Implications for the Initiation and Progress of Systemic Autoimmunity.
    Mackern-Oberti JP; Jara EL; Riedel CA; Kalergis AM
    Arch Immunol Ther Exp (Warsz); 2017 Apr; 65(2):123-136. PubMed ID: 27585815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells.
    Liao X; Reihl AM; Luo XM
    J Immunol Res; 2016; 2016():6269157. PubMed ID: 27034965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus.
    Richez C; Blanco P; Rifkin I; Moreau JF; Schaeverbeke T
    Joint Bone Spine; 2011 Mar; 78(2):124-30. PubMed ID: 20961794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiology of systemic lupus erythematosus].
    Blanco P; Pellegrin JL; Moreau JF; Viallard JF
    Presse Med; 2007 May; 36(5 Pt 2):825-34. PubMed ID: 17449371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates.
    Ketloy C; Engering A; Srichairatanakul U; Limsalakpetch A; Yongvanitchit K; Pichyangkul S; Ruxrungtham K
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):18-30. PubMed ID: 18571243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fueling autoimmunity: type I interferon in autoimmune diseases.
    Di Domizio J; Cao W
    Expert Rev Clin Immunol; 2013 Mar; 9(3):201-10. PubMed ID: 23445195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic acid recognition receptors in autoimmunity.
    Krug A
    Handb Exp Pharmacol; 2008; (183):129-51. PubMed ID: 18071658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic acid recognizing Toll-like receptors and autoimmunity.
    von Landenberg P; Bauer S
    Curr Opin Immunol; 2007 Dec; 19(6):606-10. PubMed ID: 18060756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I interferon production by nucleic acid-stimulated dendritic cells.
    Kaisho T
    Front Biosci; 2008 May; 13():6034-42. PubMed ID: 18508640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.